72603-0922 DASATINIB - CanMED: NDC

Return Home

SEER Data & Software

Observational Research in Oncology Toolbox

Product Information

CanMED: NDC

Product NDC:

72603-0922

Brand Name:

DASATINIB

Generic Name:

DASATINIB

Dosage Form Name:

TABLET, FILM COATED

Administration Route:

Oral

Substances:

Name: DASATINIB

Strength: 20.0

Unit: mg/1

Packages:

Code: 72603-0922-01

Description: 60 TABLET, FILM COATED in 1 BOTTLE (72603-922-01)

Effective Date: June 1, 2026

Discontinued:

SEER*Rx Category:

Chemotherapy

Major Class:

Tyrosine Kinase Inhibitor

Minor Class:

BCR-ABL

Orphan Drug Designation:

Status:

In Use